Opaleye Management’s Obsidian Therapeutics OBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
+75,755
New +$1.48M 0.12% 54

Other funds holding OBX

Opaleye Management's OBX Position: Q3 2026 in Review

Opaleye Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 75,755 shares worth $1.04M. The stake represents 0.12% of the portfolio and ranks #54 among its holdings.

61 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • Opaleye Management held 75,755 shares of Obsidian Therapeutics worth $1.04M as of Q3 2026.
  • Obsidian Therapeutics was a new Opaleye Management position in Q3 2026.
  • Obsidian Therapeutics made up 0.12% of Opaleye Management's portfolio in Q3 2026, its #54 holding.
  • 61 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on Opaleye Management's 13F filing for Q3 2026, filed 16 Nov 2026.